|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Study Type: | Interventional |
|---|---|
| Study Design: | Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment |
| Condition: |
Healthy |
| Intervention: |
Drug: divalproex sodium |
Participant Flow
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| No text entered. |
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
| Description | |
|---|---|
| 1 | Divalproex Sodium |
| 2 | Placebo |
| 1 | 2 | |
|---|---|---|
| STARTED | 30 | 27 |
| COMPLETED | 26 | 26 |
| NOT COMPLETED | 4 | 1 |
More Information
| Principal Investigators are NOT employed by the organization sponsoring the study. |
| There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. |
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
| Responsible Party: | Pennington Biomedical Research Center ( Corby Martin ) |
| Study ID Numbers: | 25031 |
| Study First Received: | February 2, 2006 |
| Results First Received: | April 21, 2009 |
| Last Updated: | April 21, 2009 |
| ClinicalTrials.gov Identifier: | NCT00287053 History of Changes |
| Health Authority: | United States: Institutional Review Board |